176 related articles for article (PubMed ID: 22720826)
21. Understanding and overcoming barriers to human papillomavirus vaccine acceptance.
Zimet GD
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s23-8. PubMed ID: 16520681
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus (HPV) vaccines: a Canadian update.
Foerster V; Murtagh J
Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
[TBL] [Abstract][Full Text] [Related]
23. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
Schiffman M
Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
[TBL] [Abstract][Full Text] [Related]
24. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
[TBL] [Abstract][Full Text] [Related]
25. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
26. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
27. New paradigm for prevention of cervical cancer.
Kaufmann AM; Schneider A
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):25-9. PubMed ID: 16973254
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
Knudtson M; Tiso S; Phillips S
Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus infection among young adolescents in India: impact of vaccination.
Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
[TBL] [Abstract][Full Text] [Related]
30. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus vaccine: a paradigm shift for pediatricians.
Jenson HB
Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
[TBL] [Abstract][Full Text] [Related]
32. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
33. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
34. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.
Vanslyke JG; Baum J; Plaza V; Otero M; Wheeler C; Helitzer DL
Qual Health Res; 2008 May; 18(5):584-96. PubMed ID: 18337618
[TBL] [Abstract][Full Text] [Related]
35. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
36. [Human papillomavirus vaccination. Consensus Conference in pediatric age].
Bartolozzi G; Bona G; Ciofi M; De Martino M; Di Pietro P; Duse M; Esposito S; Gasparini R; Mariani L; Marostica G; Paravati F; Plebani A; Principi N; Zuccotti GV; Tovo PA
Minerva Pediatr; 2007 Jun; 59(3):165-82. PubMed ID: 17519861
[TBL] [Abstract][Full Text] [Related]
37. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
Westra TA; Daemen T; Postma MJ; Wilschut JC
Ned Tijdschr Geneeskd; 2009; 153():A356. PubMed ID: 19930733
[TBL] [Abstract][Full Text] [Related]
38. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
Kollar LM; Kahn JA
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
[TBL] [Abstract][Full Text] [Related]
39. The Manitoba human papillomavirus vaccine surveillance and evaluation system.
Kliewer EV; Demers AA; Brisson M; Severini A; Lotocki R; Elias B; Hammond G; Wurtak G;
Health Rep; 2010 Jun; 21(2):37-42. PubMed ID: 20632523
[TBL] [Abstract][Full Text] [Related]
40. Sex, drugs, and politics: the HPV vaccine for cervical cancer.
Casper MJ; Carpenter LM
Sociol Health Illn; 2008 Sep; 30(6):886-99. PubMed ID: 18761509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
